Report cover image

AI-based Clinical Trials Market by Component (Services, Software), Function (Adverse Event Detection, Data Collection & Analysis, Patient Recruitment & Screening), Phase, Technology, Application, End-user - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 190 Pages
SKU # IRE18417768

Description

AI-based Clinical Trials Market by Component (Services, Software), Function (Adverse Event Detection, Data Collection & Analysis, Patient Recruitment & Screening), Phase, Technology, Application, End-user - Global Forecast 2024-2030


The AI-based Clinical Trials Market size was estimated at USD 6.52 billion in 2023 and expected to reach USD 7.73 billion in 2024, at a CAGR 18.79% to reach USD 21.79 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the AI-based Clinical Trials Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the AI-based Clinical Trials Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the AI-based Clinical Trials Market, highlighting leading vendors and their innovative profiles. These include AiCure, LLC, Aiforia Technologies Oyj, Antidote Technologies, Inc., Ardigen S.A., Avantor, Inc., BioAge Labs, BioSymetrics Inc., Deep 6 AI Inc., Envisagenics, Euretos Services BV, Exscientia PLC, GNS Healthcare, Google LLC by Alphabet Inc., Innoplexus AG, InSilico Medicine, Intel Corporation, International Business Machines Corporation, Koninklijke Philips N.V., Median Technologies, Nuritas Limited, Pharmaceutical Pipeline Enhancement Strategies, LLC, Saama Technologies, Inc., Symplr Software LLC, Trials.ai, Inc. by ZS Associates, Inc., and Unlearn.AI, Inc..

Market Segmentation & Coverage

This research report categorizes the AI-based Clinical Trials Market to forecast the revenues and analyze trends in each of the following sub-markets:

Component

Services
  • Software
  • Function

    Adverse Event Detection
  • Data Collection & Analysis
  • Patient Recruitment & Screening
  • Predictive Modeling
  • Trial Design & Optimization
  • Phase

    Phase-I
  • Phase-II
  • Phase-III
  • Technology

    Machine Learning
  • Natural Language Processing
  • Application

    Cardiovascular Diseases
  • Infectious Diseases
  • Metabolic Diseases
  • Neurological Diseases
  • Oncology
  • End-user

    Academic & Research Institutes
  • Contract Research Organization
  • Hospitals
  • Pharmaceutical & Biopharmaceutical Companies
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the AI-based Clinical Trials Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the AI-based Clinical Trials Market?
    3. What are the technology trends and regulatory frameworks in the AI-based Clinical Trials Market?
    4. What is the market share of the leading vendors in the AI-based Clinical Trials Market?
    5. Which modes and strategic moves are suitable for entering the AI-based Clinical Trials Market?


    Note: PDF & Excel + Online Access - 1 Year

    • Table of Contents

    190 Pages
    1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. AI-based Clinical Trials Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Need for artificial Intelligence which helps in boosting and improving clinical trials
    5.1.1.2. Rising needs to reduce healthcare costs and declining hardware costs
    5.1.1.3. Increased adoption of AI-based drug development technology by most of the pharmaceutical companies
    5.1.2. Restraints
    5.1.2.1. Lack of personal involvement leading to a rise in unemployment rates
    5.1.2.2. Possibility of a defective diagnosis
    5.1.3. Opportunities
    5.1.3.1. Technological advancements and innovations in AI-based clinical trials
    5.1.3.2. Major pharmaceutical companies are ensuring more joint ventures and partnerships with AI vendors
    5.1.4. Challenges
    5.1.4.1. Concerns associated with the adoption of EHR interoperability
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. AI-based Clinical Trials Market, by Component
    6.1. Introduction
    6.2. Services
    6.3. Software
    7. AI-based Clinical Trials Market, by Function
    7.1. Introduction
    7.2. Adverse Event Detection
    7.3. Data Collection & Analysis
    7.4. Patient Recruitment & Screening
    7.5. Predictive Modeling
    7.6. Trial Design & Optimization
    8. AI-based Clinical Trials Market, by Phase
    8.1. Introduction
    8.2. Phase-I
    8.3. Phase-II
    8.4. Phase-III
    9. AI-based Clinical Trials Market, by Technology
    9.1. Introduction
    9.2. Machine Learning
    9.3. Natural Language Processing
    10. AI-based Clinical Trials Market, by Application
    10.1. Introduction
    10.2. Cardiovascular Diseases
    10.3. Infectious Diseases
    10.4. Metabolic Diseases
    10.5. Neurological Diseases
    10.6. Oncology
    11. AI-based Clinical Trials Market, by End-user
    11.1. Introduction
    11.2. Academic & Research Institutes
    11.3. Contract Research Organization
    11.4. Hospitals
    11.5. Pharmaceutical & Biopharmaceutical Companies
    12. Americas AI-based Clinical Trials Market
    12.1. Introduction
    12.2. Argentina
    12.3. Brazil
    12.4. Canada
    12.5. Mexico
    12.6. United States
    13. Asia-Pacific AI-based Clinical Trials Market
    13.1. Introduction
    13.2. Australia
    13.3. China
    13.4. India
    13.5. Indonesia
    13.6. Japan
    13.7. Malaysia
    13.8. Philippines
    13.9. Singapore
    13.10. South Korea
    13.11. Taiwan
    13.12. Thailand
    13.13. Vietnam
    14. Europe, Middle East & Africa AI-based Clinical Trials Market
    14.1. Introduction
    14.2. Denmark
    14.3. Egypt
    14.4. Finland
    14.5. France
    14.6. Germany
    14.7. Israel
    14.8. Italy
    14.9. Netherlands
    14.10. Nigeria
    14.11. Norway
    14.12. Poland
    14.13. Qatar
    14.14. Russia
    14.15. Saudi Arabia
    14.16. South Africa
    14.17. Spain
    14.18. Sweden
    14.19. Switzerland
    14.20. Turkey
    14.21. United Arab Emirates
    14.22. United Kingdom
    15. Competitive Landscape
    15.1. FPNV Positioning Matrix
    15.2. Market Share Analysis, By Key Player
    15.3. Competitive Scenario Analysis, By Key Player
    16. Competitive Portfolio
    16.1. Key Company Profiles
    16.1.1. AiCure, LLC
    16.1.2. Aiforia Technologies Oyj
    16.1.3. Antidote Technologies, Inc.
    16.1.4. Ardigen S.A.
    16.1.5. Avantor, Inc.
    16.1.6. BioAge Labs
    16.1.7. BioSymetrics Inc.
    16.1.8. Deep 6 AI Inc.
    16.1.9. Envisagenics
    16.1.10. Euretos Services BV
    16.1.11. Exscientia PLC
    16.1.12. GNS Healthcare
    16.1.13. Google LLC by Alphabet Inc.
    16.1.14. Innoplexus AG
    16.1.15. InSilico Medicine
    16.1.16. Intel Corporation
    16.1.17. International Business Machines Corporation
    16.1.18. Koninklijke Philips N.V.
    16.1.19. Median Technologies
    16.1.20. Nuritas Limited
    16.1.21. Pharmaceutical Pipeline Enhancement Strategies, LLC
    16.1.22. Saama Technologies, Inc.
    16.1.23. Symplr Software LLC
    16.1.24. Trials.ai, Inc. by ZS Associates, Inc.
    16.1.25. Unlearn.AI, Inc.
    16.2. Key Product Portfolio
    17. Appendix
    17.1. Discussion Guide
    17.2. License & Pricing
    FIGURE 1. AI-BASED CLINICAL TRIALS MARKET RESEARCH PROCESS
    FIGURE 2. AI-BASED CLINICAL TRIALS MARKET SIZE, 2023 VS 2030
    FIGURE 3. AI-BASED CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. AI-BASED CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. AI-BASED CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. AI-BASED CLINICAL TRIALS MARKET DYNAMICS
    FIGURE 7. AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
    FIGURE 8. AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
    FIGURE 10. AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
    FIGURE 12. AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
    FIGURE 14. AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
    FIGURE 16. AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
    FIGURE 18. AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. AMERICAS AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 20. AMERICAS AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 21. UNITED STATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 22. UNITED STATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 23. ASIA-PACIFIC AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 24. ASIA-PACIFIC AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 25. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 26. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 27. AI-BASED CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 28. AI-BASED CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us